Too many private investors on the cc.
No wonder they don't say to much, that is all being said upstairs after the inv confc's and at trade confc's.
If that many people call in about shady financings, tell the world the story, why isn't the pps higher, etc. imagine the nuts calling the clinics and PPHM's HQ and emailing them...
Mgmt is doing fine, it's the investors that need to grow up.
Not tootin their horn is the way to go right now, they only need Wall St's attention right now. Wall St will sell all day to retail when they are in deep have run the pps some and are willing to book some profits.
PH-IB ending could see a VRTX run +, especially if they start the pr machine....HIV, CMV, 6mg/kg dose,,Influenza, PhIB results, PHII (at NIAID???), Cancer, Licensing, VC $$.....
Run the pps some from here until Sep and do one deal and maybe some Bio Shield $$$ in the 4th qtr and the bank is full and more data to follow quickly....Little later than I'd hoped, but by years end is feasible.
Any thoughts on that 6mg/kg dose and results in the fall at a HEPC Confc? Wonder how good those reults are? Are they in already and they are waiting to see how long an immune response lasts? Was it a "cure"?
Avian Flu/Influenza: You don't get sent to Utah St and the SRI if the data is not good...I think they are playing this one close to the vest. Would love to see what Pitt/Kurilla discussed at the ASM....
And why didn't one of the retail folks ask about the govt data? Would have loved to hear that question over the silly ones asked about the pps lacking and shady financings.....
